The evidence behind photobiomodulation in laboratory settings is parameter-sensitive. Research proposes that red light therapy (RLT) and near-infrared therapy (NIR) can be absorbed by cellular photoacceptors, with cytochrome c oxidase often identified as a leading candidate. Downstream signaling may increase ATP availability and influence fibroblast proliferation, collagen expression, and matrix remodeling. A randomized controlled trial by Wunsch and Matuschka reported increased ultrasonographically measured intradermal collagen density after repeated red or broad-spectrum light exposure, while cell studies have found increased fibroblast viability and type I collagen expression with red/NIR combinations. These findings describe PBM research, not a product-specific claim. Clinical research, device physics, and the OvationULT's FDA registered ILY intended use remain distinct questions.
What does peer-reviewed research show about PBM fibroblast stimulation and collagen?
Photobiomodulation (PBM) is the use of non-ionizing red or near-infrared light at parameters intended to produce photochemical rather than destructive thermal effects. In skin-focused research, the relevant cells include dermal fibroblasts, which synthesize collagen and other extracellular-matrix components. Published results suggest that specific wavelengths and doses can alter cellular signaling associated with fibroblast behavior and collagen metabolism.
The strongest direct clinical evidence cited often is the randomized controlled trial by Wunsch and Matuschka (2014). In 136 volunteers, 113 participants were assigned to treatment groups and 23 to control; treatments were delivered twice weekly for 30 sessions. The investigators reported improvements in roughness and blinded photographic assessments, plus an increase in collagen density measured by ultrasound. However, their red-only and broader-spectrum arms used different irradiances and treatment durations. The trial supports a relationship under its own specific protocol, not a universal dose rule.
The laboratory literature helps explain why the clinical result is biologically plausible. Tian, Kim, and Lee (2012) exposed UVB-stressed cultured human skin cells to LED wavelengths and found that 630, 660, 830, and 850 nm increased viable fibroblast numbers and type I collagen expression. Their 630/850 nm combination was associated with stronger outcomes than single wavelengths. Because this was an in-vitro model, it cannot predict an individual client's appearance or establish a clinical treatment result.
A newer human-fibroblast study likewise found increased cell number and collagen types I and III after a defined three-session laser protocol in culture, as reported by Garcia et al. (2024). It strengthens the mechanistic case for PBM fibroblast stimulation while highlighting the limits of extrapolation. Living skin adds pigmentation, thickness, perfusion, age, prior UV exposure, and other complex biological variables.
How does photobiomodulation signal from cytochrome c oxidase to fibroblasts?
The leading mechanistic model begins in the mitochondria. The skin review by Avci et al. (2013) describes cytochrome c oxidase in the respiratory chain as a proposed photoacceptor for red and NIR PBM, while acknowledging that the mechanism is not fully settled. One hypothesis is that light absorption alters nitric-oxide interaction with the enzyme, supporting electron transport, mitochondrial respiration, and ATP production.
ATP is not collagen, and keeping that distinction clear maintains scientific accuracy. ATP supplies usable cellular energy, while shifts in redox state, reactive oxygen species, calcium signaling, and transcription factors may change how a fibroblast proliferates or produces extracellular-matrix proteins. Research cited in the review reports increases in procollagen, collagen, basic fibroblast growth factor, and fibroblast proliferation in selected in-vitro and animal experiments. The evidence suggests a signaling cascade, not a simple switch that forces fibroblasts to produce collagen whenever light is present.
A practical way to read the mechanism is as a sequence rather than a promise:
-
Select a researched wavelength range: Use red or NIR wavelengths that have been studied in PBM literature rather than treating color alone as the active variable.
-
Verify irradiance at the treatment plane: Measure power density where the body receives light, not only at a diode or in a marketing specification.
-
Calculate radiant exposure: Multiply irradiance by exposure time to express incident energy density in J/cm², then distinguish surface exposure from energy reaching a cellular target.
-
Compare the full protocol: Assess wavelength, dose, schedule, area, distance, and study population together before making a research-based statement.
-
Keep the conclusion bounded: Describe published findings as evidence about a protocol or mechanism, not as a guaranteed outcome.
Why are 635 nm red light and 850 nm near-infrared therapy used together for PBM?
The phrase "standard PBM wavelengths" can mislead if it implies a single clinically proven pair. There is no single wavelength or radiant exposure that every peer-reviewed study identifies as optimal. Still, 635 nm red light and 850 nm NIR are common, research-aligned selections within PBM literature due to their different optical paths through tissue.
Red light near 635 nm is generally absorbed more superficially than NIR and is relevant to upper-dermal exposure. NIR near 850 nm is less visible and typically reaches deeper tissue layers, although exact penetration is influenced by skin optical properties and cannot be inferred from wavelength alone. The 2012 cultured-cell study tested 630 and 850 nm among the wavelengths that increased fibroblast viability and type I collagen expression, including a 630/850 nm combination.
|
Research Metric |
Red (635 nm) |
Near-Infrared (850 nm) |
|
Relative Tissue Path |
More superficial, with emphasis on upper dermis. |
Deeper optical path through tissue than visible red light. |
|
Cellular Target in Research |
Keratinocytes and dermal fibroblasts, via mitochondrial signaling. |
Dermal fibroblasts and deeper tissue cells, via mitochondrial signaling. |
|
Published Evidence |
Red-range studies report fibroblast and procollagen responses under specific conditions. |
850 nm increased metabolic activity in dermal fibroblasts under in-vivo-like conditions. |
|
Useful Interpretation |
A researched red band, not proof that all 635 nm protocols work alike. |
A researched NIR band, not proof that deeper penetration produces a specific clinical outcome. |
What does the published evidence show, and what does it not establish?
The published record supports three careful statements. First, red and NIR PBM have credible mechanistic pathways involving mitochondrial signaling and fibroblasts. Second, several in-vitro studies and controlled human studies report collagen-related changes under defined protocols. Third, the evidence is heterogeneous, so outcomes cannot be reduced to a single wavelength label or a universal session prescription.
The literature does not establish that any device using red and NIR LEDs will reproduce these findings. It does not establish that a surface irradiance value alone predicts cellular production in every individual. It also does not support presenting collagen stimulation as a medical treatment or guaranteed outcome without an appropriate regulatory clearance.
For a commercial facility, discuss the research responsibly, disclose technical parameters, and separate peer-reviewed evidence from device claims. Refer clients seeking dermatologic evaluation or individualized care to a qualified clinician.
How should a clinic interpret therapeutic irradiance, dose, and measurement location?
Therapeutic irradiance is not a universal threshold number. In a research context, it means the measured power density was part of a complete protocol that produced a reported outcome. A defensible comparison asks where the measurement was taken, whether the measurement is uniform across the treatment area, how long exposure lasts, and what radiant exposure follows.
Heating skin is not the same as delivering a photobiomodulation dose at therapeutic irradiance levels at the cellular level. Irradiance is power per area, expressed as mW/cm²; fluence or radiant exposure is irradiance multiplied by time, expressed as J/cm². Neither value tells an operator how much energy reaches a fibroblast below the surface, because reflection, scattering, absorption, and tissue composition alter the light path.
The LightLab irradiance measurement methodology makes the measurement location explicit for Body Balance System equipment. The OvationULT array utilizes 28,443 total diodes (22,755 at 635 nm red and 5,688 at 850 nm near-infrared). The array specification and measured irradiance represent physical equipment data, whereas collagen findings represent academic research findings.
At 65 mW/cm² at the acrylic surface (LightLab methodology), a typical 15-minute exposure corresponds to 0.065 W/cm² × 900 seconds = 58.5 J/cm² at the acrylic surface. This is incident radiant exposure at the stated measurement plane, not a claim about energy delivered to dermal fibroblasts or total joules absorbed by a client.
How does Body Balance System separate PBM research from OvationULT's ILY intended use?
Body Balance System, based in Las Vegas, Nevada, designs commercial full-body red light therapy beds. The OvationULT is an FDA registered Class II medical device under Registration #3010627475, product code ILY. Its cleared intended-use scope includes:
-
Topical heating
-
Temporary relief of minor muscle and joint pain and stiffness
-
Temporary relief of minor arthritis pain
-
Relaxation of muscle spasms
-
Temporary increase of local blood circulation
For physical delivery, the OvationULT utilizes a zero-gravity canopy design at 0 to 2 inch proximity and 10 to 20 minute session times (typical 15). It delivers therapeutic irradiance at the wavelengths studied in PBM research. These physical design, measurement, and session facts do not attribute collagen or skin-health claims to the OvationULT.
That separation is vital for commercial operators. A product should be evaluated for its listed intended use, build quality, proximity, output measurement, and workflow. Academic PBM literature may be evaluated for its study design and reported biological findings.
To continue the equipment due-diligence conversation, explore Body Balance System's guides to how red light therapy works, close-proximity light delivery, commercial bed components, and what FDA registered actually means for red light therapy.
Frequently Asked Questions about Red Light Therapy, PBM, and Research
Does red light therapy stimulate collagen production according to peer-reviewed research?
Peer-reviewed research suggests that selected red and near-infrared PBM protocols can influence fibroblast activity and collagen-related measures in study environments. Wunsch and Matuschka reported increased ultrasonographic collagen density in a controlled human study, while cell studies report collagen expression changes. Results depend on wavelength, dose, schedule, and model.
Does PBM increase collagen simply by boosting ATP in fibroblasts?
PBM does not convert ATP into collagen. Published mechanistic reviews identify cytochrome c oxidase as a photoacceptor and describe increased mitochondrial respiration and ATP as part of an initial signaling sequence. Subsequent changes in redox signaling, transcription, and fibroblast activity contribute to research findings under specific conditions.
Are 635 nm and 850 nm the only wavelengths supported by PBM research?
No. PBM research covers several red and near-infrared wavelengths. The 635 nm and 850 nm bands are common research-aligned choices. A cultured-cell study tested 630 and 850 nm, among other wavelengths, reporting increased viable fibroblasts and type I collagen expression under its specific protocol.
What irradiance is considered therapeutic in collagen-focused PBM research?
There is no single therapeutic irradiance cutoff. Research protocols must be evaluated as a complete combination of wavelength, measured irradiance, exposure time, fluence, treatment schedule, and tissue model. The 65 mW/cm² output at the acrylic surface is an OvationULT physical measurement, not a claim of a clinical dose inside human skin.
Does a 15-minute OvationULT session claim to increase collagen?
No. A 10 to 20 minute session (typical 15) describes the operational session window for the OvationULT. The device is an FDA registered Class II medical device (product code ILY) with a topical-heating and pain-relief intended use. Academic collagen observations are attributed to peer-reviewed research studies, not to the product.
How should a clinic discuss PBM research responsibly?
A clinic should state that published PBM research suggests possible effects on mitochondrial signaling and fibroblasts under defined laboratory protocols. Facilities should avoid guarantees, adhere strictly to FDA-cleared intended uses, and separate academic literature from device claims.